Strategic Financial Concepts LLC purchased a new position in Solventum Co. (NYSE:SOLV - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 14,992 shares of the company's stock, valued at approximately $990,000.
Other hedge funds have also recently modified their holdings of the company. Modus Advisors LLC purchased a new stake in Solventum during the fourth quarter valued at $25,000. Copeland Capital Management LLC purchased a new stake in Solventum during the third quarter valued at $26,000. Stonebridge Financial Group LLC purchased a new stake in Solventum during the fourth quarter valued at $26,000. Crews Bank & Trust purchased a new stake in Solventum during the fourth quarter valued at $32,000. Finally, True Wealth Design LLC grew its holdings in Solventum by 23,550.0% during the third quarter. True Wealth Design LLC now owns 473 shares of the company's stock valued at $33,000 after purchasing an additional 471 shares during the period.
Analysts Set New Price Targets
SOLV has been the subject of several recent research reports. Mizuho initiated coverage on Solventum in a report on Wednesday, December 4th. They set a "neutral" rating and a $70.00 price target for the company. Piper Sandler boosted their price target on Solventum from $71.00 to $75.00 and gave the company a "neutral" rating in a report on Friday, November 8th. Finally, Morgan Stanley boosted their price target on Solventum from $60.00 to $73.00 and gave the company an "equal weight" rating in a report on Monday, November 11th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $68.29.
Check Out Our Latest Stock Analysis on SOLV
Solventum Stock Performance
Shares of NYSE SOLV traded down $1.42 during mid-day trading on Friday, reaching $73.08. The company's stock had a trading volume of 570,685 shares, compared to its average volume of 891,579. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. The stock has a fifty day moving average of $71.07 and a two-hundred day moving average of $68.95. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05.
Solventum Profile
(
Free Report)
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Read More
Before you consider Solventum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solventum wasn't on the list.
While Solventum currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
